Sandoz 1st to reveal US biosimilar application
This article was originally published in SRA
Executive Summary
Some company had to be the first to file a biosimilar application with the US Food and Drug Administration under the approval pathway created by Congress in 2010 as part of the Affordable Care Act. It seems Sandoz may be that firm.